Magnetar Financial’s Senti Biosciences Holdings SNTI Stock Holding History

Magnetar Financial’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-57,650	Closed	-$5.69M	–	1814
2022 Q1	$5.69M	Sell	57,650 -1,316	-2%	-$130K	0.06%	318
2021 Q4	$5.81M	Sell	58,966 -1,034	-2%	-$103K	0.06%	333
2021 Q3	$5.96M	Hold	60,000	–	–	0.06%	320
2021 Q2	$5.96M	Buy	+60,000	New	+$5.99M	0.06%	327

Other funds holding SNTI

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Intel Corp Santa Clara, California $621M AUM 34.06% 1-Year Est. Return

FMN

Financial Management Network Mission Viejo, California $697M AUM 21.37% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Kingfisher Capital Charlotte, North Carolina $437M AUM 41.72% 1-Year Est. Return

Magnetar Financial's SNTI Position: Q2 2022 in Review

Magnetar Financial sold out of Senti Biosciences Holdings (SNTI) in Q2 2022, closing a stake of 57,650 shares — an estimated $5.69M sold.

Magnetar Financial first reported a position in SNTI in Q2 2021 and held it in 4 quarters. The position peaked at $5.96M in Q3 2021. 22 funds tracked by Wall St. Rank hold SNTI as of Q2 2022.

Magnetar Financial reported no remaining Senti Biosciences Holdings position as of Q2 2022 after selling out during the quarter.
Magnetar Financial sold 57,650 Senti Biosciences Holdings shares in Q2 2022, an estimated $5.69M.
Magnetar Financial first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 4 quarters.
Magnetar Financial's Senti Biosciences Holdings position peaked at $5.96M in Q3 2021.
22 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2022.

Based on Magnetar Financial's 13F filing for Q2 2022, filed 15 Aug 2022.